Canadian Society of Nuclear Medicine
La Société canadienne de médecine nucléaire

Posted 28/06/02

THE RESPONSE FROM THE FEDERAL GOVERNMENT ON THE CSNM POSITION PAPER ON PET HAS FINALLY BEEN RECEIVED. THE FEDERAL GOVERNMENT HAS ALSO AGREED TO SUPPORT THE CREATION OF AN EXPERT WORKING GROUP WHO WILL HELP DEFINE THE EXISTING LEGISLATION WHILE TAKING INTO ACCOUNT THE SPECIAL ASPECTS OF PET RADIOPHARMACEUTICAL COMPARED TO THE MORE CURRENT DRUGS. 

 ATTACHED ARE:

• THE DRAFT ISSUE ANALYSIS SUMMARY (THE CANADIAN REGULATORY FRAMEWORK FOR RADIOPHARMACEUTICALS)
  256kb posted 28/06/02

• A LETTER FROM JULIA HILL, ASSOCIATE DIRECTOR GENERAL, HEALTH CANADA, REQUESTING MEMBER PARTICIPATION FOR THE NEW EXPERT WORKING GROUP

• A LETTER FROM JULIA HILL, ASSOCIATE DIRECTOR GENERAL, HEALTH CANADA, REQUESTING COMMENTS ON THE DRAFT ISSUE ANALYSIS SUMMARY 

• DRAFT TERMS OF REFERENCE – EXPERT WORKING GROUP ON POSITRON EMITTING RADIOPHARMACEUTICALS (PERs)

 G. Matte
Chairman Radiopharmacy Councils CSNM
Co-Chairman Alliance for Nuclear Medicine in Canada